TEVA
Teva Pharma Industries Ltd
36.80$
+0.7%
vs. previous close
Closing price · As of: Aug 14, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.3% | 28.2% | 23.9% | 15.7% | 13.0% | 3.2% | 7.3% | 5.0% | 10.7% | 8.6% | 7.5% | 9.6% | |
| 7.4% | 6.7% | 7.0% | 9.4% | 9.8% | 2.5% | 9.3% | 8.4% | 8.8% | 7.3% | 6.4% | 5.8% | |
| 0.5% | 0.6% | 0.6% | 0.6% | 0.8% | 0.1% | 0.8% | 0.7% | 0.8% | 0.8% | 0.7% | 0.9% | |
| 1.4% | 8.5% | 9.8% | 93.9% | 30.6% | 11.4% | 41.1% | 4.6% | 9.2% | – | – | – | |
| 1.4% | 4.9% | 5.6% | -1.6% | -9.7% | -0.7% | -13.1% | -10.7% | 9.1% | -0.5% | -2.6% | -7.9% | |
| 4.6% | 3.9% | 4.1% | 3.9% | 3.5% | 0.7% | 3.5% | 3.5% | 3.7% | 3.3% | 3.0% | 2.9% | |
| -7.2% | -28.3% | -163.2% | 9.7% | 9.9% | 8.0% | 5.2% | 9.6% | 4.4% | 6.1% | 4.8% | 4.3% | |
| 5.7% | 5.9% | 7.1% | 5.2% | 0.1% | 0.3% | – | – | – | – | – | – | |
| -2.5% | -2.2% | 126.1% | 0.0% | -9.5% | -11.7% | – | – | – | – | – | – | |
| -6.0% | -2.0% | 119.9% | -22.3% | -17.4% | -11.0% | -11.3% | -10.5% | -9.2% | -10.7% | -9.9% | -10.5% | |
| -11.7% | 24.5% | 115.1% | -25.7% | -17.8% | -1.4% | -11.3% | -13.7% | -10.0% | -12.1% | -10.8% | -12.5% | |
| 5.9% | 24.0% | -27.2% | -0.1% | 4.3% | 4.3% | 1.2% | 0.1% | 4.3% | 2.5% | 0.4% | 1.5% | |
| 20.7% | 24.3% | 19.7% | 11.8% | 9.5% | 2.5% | 3.8% | 1.5% | 7.0% | 5.3% | 4.5% | 6.7% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.